UNIHOLDING CORP
10-Q/A, 1999-01-14
MEDICAL LABORATORIES
Previous: INCOMNET INC, 8-K, 1999-01-14
Next: UNIHOLDING CORP, 10-Q, 1999-01-14



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  FORM 10-Q/A-1


[X] Quarterly Report Pursuant to Section 13 or 15(d) of the Securities  Exchange
Act of 1934

For the quarterly period ended       August 31, 1998

[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934

For the transition period            to

                           Commission File No. 0-9833

                             UNIHOLDING CORPORATION
             (Exact name of registrant as specified in its charter)


         Delaware                              58-1443790
- - ----------------------------               -----------------------
(State or other jurisdiction                (I.R.S. Employer
of incorporation)                           Identification Number)


96 Spring Street, 8th Floor, New York, New York               10012
- - -----------------------------------------------            -----------
(Address of principal executive offices)                    (Zip Code)


Registrant's telephone number, including area code:  (212) 219-9496


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was

required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No___


<PAGE>



PART I - FINANCIAL INFORMATION
ITEM 2 - MANAGEMENT'S DISCUSSION AND ANALYSIS -
                  IMPACT OF YEAR 2000

IMPACT OF YEAR 2000

As  previously  reported in the  Company's  Form 10-K for the year ended May 31,
1998, most of the Company's  laboratories are faced with "Year 2000" remediation
issues.  Many computer  programs were written with a two digit date field and if
these  programs  are not made  Year  2000  compliant,  they  will be  unable  to
correctly process date information on or after the Year 2000. While these issues
impact all of the Company's  data  processing  systems to some extent,  they are
most  significant  in  connection  with  patient-  related  computer   programs.
Moreover,  remediation efforts go beyond the Company's internal computer systems
and require  coordination  with  clients,  suppliers  and other third parties to
assure that their  systems  and  related  interfaces  are  compliant.  Given the
different  computer systems  operated by the Company's  business units, the type
and  extent  of  the  Year  2000  issues  and  the  cost  of  remediation   vary
significantly  among the  Company's  laboratories.  Failure  to  achieve  timely
remediation   of  computer   systems  that  process   client   information   and
transactions,  and of all other  systems  with  embedded  technologies  that are
critical to the Company's  operations,  would have a material  adverse effect on
the Company's business, operations and financial results.

In response  to the Year 2000  concerns,  the  Company  created a Year 2000 Task
Force to coordinate  and monitor the  laboratories'  progress in their Year 2000
remediation  efforts. The Task Force reports directly to the Company's executive
management,  provides  regular  progress  reports to executive  management,  and
regularly meets with executive management to discuss its reports.

The Company's  initial plans called for all critical systems to be renovated and
compliance testing underway by the end of calendar 1998. As of January 11, 1999,
the Company  estimated that  approximately 40 to 50% of its critical systems had
been renovated and  compliance  testing  underway,  and that the balance will be
renovated by June 30, 1999.  As the Company  uses many  computerized  laboratory
machinery  manufactured,  provided and maintained by third-party vendors, it has
requested  each of  those  vendors  to  provide  the  Company  with  appropriate
certification  that the machinery is Year 2000 compliant.  The Company currently
estimates that approximately 40% of such certification has been received, and it
continuously  presses those vendors that have not responded.  Acceptance testing
is  scheduled  to take place  through  mid-1999  with time frames  differing  by
laboratory  unit.  Completion of any third party interface  testing is dependent
upon those third parties completing their own internal remediation.  The Company
could be adversely affected to the extent third parties with which it interfaces
(including some of the Company's  customers)  have not properly  addressed their
Year 2000 issues.  The Company  currently  develops  contingency plans to handle
critical areas in the event remediation is not fully successful or is beyond the
Company's control.

In fiscal 1998,  the Company spent  approximately  $0.5 million on its Year 2000
remediation  efforts.  The Company currently  anticipates  expenditures for Year
2000  remediation  efforts  and  testing  in the range of $0.5  million  to $1.0
million in fiscal  1999,  and of  approximately  $0.2  million  in fiscal  2000.
Substantially  all of the  expenditures  already  made are  related to  internal
payroll  and   external   consultants,   while   future   expenditures   include
approximately  $0.5 for computer  equipment that was not compliant and should be
replaced.

The costs of the  project  and the date on which the  Company  believes  it will
complete the Year 2000  modifications  are based on management's best estimates,
which were derived utilizing  numerous  assumptions of future events,  including
the continued  availability  of certain  resources and other  factors.  However,
there can be no  guarantee  that these  estimates  will be  achieved  and actual
results could differ materially from those anticipated.






                                   SIGNATURES


         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                             UniHolding Corporation


                             By: BRUNO ADAM
                                 ------------------------
                                 Bruno Adam, CFO




Date:    January 12, 1999






© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission